30 Day Trial

Orthofix Names Jon Serbousek as Successor to Retiring President & CEO

Share:

Orthofix Medical named Jon Serbousek as President of its Global Spine business effective August 5, 2019, and successor to Brad Mason, retiring President and Chief Executive Officer, to be effective in 4Q19.

Orthofix realigned its business units in 2Q18, arranging the segments into Global Orthofix Extremities and Global Orthofix Spine and naming leadership from within the company. Mr. Serbousek will serve as interim President of the spine side following the termination of former leadership, announced in a July SEC filing

Mr. Serbousek's 30+ years of medical device experience includes multiple leadership positions in ortho, spine, biologics and sports medicine divisions at Biomet, Medtronic and DePuy Orthopedics.

“Jon’s expertise and proven track record are perfectly aligned with our business composition and make him an exceptional choice to lead the company as President and CEO,” said Mr. Mason. “With the recent leadership change in our spine business, I am pleased that Jon has agreed to serve as the President of Global Spine on an interim basis. This will give him time to focus on our needs and opportunities in that business before he takes on the broader CEO role, which should help ensure a seamless leadership transition for the benefit of all Orthofix stakeholders."

Mr. Mason became the company's President and Chief Executive Officer in 2013 after previously serving as Group President, North America from 2008 through 2009, and as a Strategic Advisor from 2009 through 2010. Prior to its acquisition by Orthofix, Mason was Founder, President and Chairman of Breg. 

Sources: Orthofix Medical Inc.; ORTHOWORLD Inc.